Skip to main content

CareDx to Report Third Quarter 2025 Financial Results on November 4, 2025

CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced it will report financial results for the third quarter 2025 after market close on Tuesday, November 4, 2025. The Company will host a webcast and conference call that day at 1:30 p.m. PT / 4:30 p.m. ET.

A live and archived webcast of the conference call can be accessed on the Events & Presentations section of CareDx’s Investor Relations website at investors.caredx.com. To participate in the live conference call via telephone, register here. Upon registering, a dial-in number and unique PIN will be provided.

About CareDx – The Transplant Company

CareDx, Inc., headquartered in Brisbane, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.

Source: CareDx, Inc.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  221.09
+3.14 (1.44%)
AAPL  259.58
+1.13 (0.44%)
AMD  234.99
+4.76 (2.07%)
BAC  51.76
+0.66 (1.29%)
GOOG  253.73
+1.20 (0.48%)
META  734.00
+0.59 (0.08%)
MSFT  520.56
+0.02 (0.00%)
NVDA  182.16
+1.88 (1.04%)
ORCL  280.07
+7.41 (2.72%)
TSLA  448.98
+10.01 (2.28%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.